08.30 – 10.30
Venue: Amphitheatre Havane
Presentations are 6 minutes in duration, followed by 2 minutes discussion
|
Chairperson: H. Ahmadieh IRAN
Moderator: C. Aras TURKEY |
08.30 |
H. Ahmadieh, M. Mohammadzadeh, A. Rajati-Haghi, A. Ramezani, M. Entezari IRAN
Effect of Oral Colchicine on the Rate of Proliferative Vitreoretinopathy after Scleral Buckling; a Randomized,
Placebo-Controlled Clinical Trial |
08.38 |
H. Ahmadieh, T. Banaee, H. Behboudi, A. Ramezani, M. Movaseghi IRAN
The effect of combined 5-fluorouracil, low molecular weight heparin, dexamethasone and oral colchicine on the rate of
retinal redetachment in established PVR |
08.46 |
A. Yassine, R. Tadayoni, B. Haouchine, P. Massin, A. Gaudric FRANCE
Macular pseudoholes: Various aspects of Spectral Domain Optical Coherence Tomograhy. Differential diagnosis versus
lamellar macular holes |
08.54 |
M. Antonia, R. Reis, V. Miranda, N. Ferreira, A. Meireles PORTUGAL
Primary vitrectomy in regmatogeneous retinal detachment with a minimum follow-up of 12 months |
09.02 |
C. Aras, Y. Ozyazgan, A. Sarici TURKEY
Retinal Debridement for Retinal Detachment Associated with Acute Retinal Necrosis |
09.10 |
C. Aras, M. Bilgec, S. Arvas, G. Muftuoglu, S. Akar TURKEY
Autologus choroid and RPE grafting in massive submacular haemorrhage due to AMD |
09.18 |
R. Avci, N. Yargýc, B. Kaderlý, U.U. Inan TURKEY
Correlation of macular hole stage, closing pattern of macula and presence of photoreceptor inner/outer segment junction
in optical coherence tomography and visual recovery after macular hole surgery |
09.26 |
M.A. Awan, D. Lyall, Z. Koshy UK
The tangential, circumferential, scleral tunnel in 20g transconjunctival sutureless vitrectomy: OCT aided analysis
of wound integrity |
09.34 |
C. Basdekidou, A. Guez, F. Metge, P. Dureau, G. Caputo FRANCE
Pediatric chorioretinal coloboma associated with retinal detachment |
09.42 |
A. Boixadera, V. Martinez-Castillo, M.A. Zapata, J. Garcia-Arumí SPAIN
Epiretinal membrane after pseudophakic rhegmatogenous retinal detachment repair by pars plana vitrectomy alone.
Incidence and visual outcomes |
09.50 |
C.J.F. Boon, K.F. de Nie, B.J. Klevering, M.A.D. Tilanus THE NETHERLANDS
Pars plana vitrectomy for bothersome primary vitreous floaters: complications and patient satisfaction. |
09.58 |
S. Kumar Boral, A. Das, T.K. Sinha, S. Mandal, D. Chakraborty INDIA
Microincision vitrectomy (23G) – is it a better alternative to 20G in pseudophakic failed retinal detachment (RD) cases? |
10.06 |
M. Coppola, L. Biraghi, P. Arpa ITALY
The use of perfluorobutylpentane (F4H5) to dissolve silicone oil from the surface of a silicone IOL |
10.14 |
N. Cortes, E. Rodriguez de la Rua, L. Manzanas, M. Lopez, J. Pastor SPAIN
Associated retinal and choroidal detachment: Visual and anatomical outcomes |
10.22 |
A. Das, S. Boral, T. Sinha, D. Chakraborty INDIA
Outcome of surgical treatment of symptomatic lamellar macular hole |
10.30 |
End of session |
11.00 – 13.00
Venue: Amphitheatre Havane
Presentations are 6 minutes in duration, followed by 2 minutes discussion
|
Chairperson: F. Bandello ITALY
Moderator: R. Schlingemann THE NETHERLANDS |
11.00 |
A. Abu El-Asrar, S. Struyf, G. Opdenakker, J. Van Damme, K. Geboes SAUDI ARABIA
Expression of stem cell factor/c-kit signaling pathway components in diabetic fibrovascular epiretinal membranes |
11.08 |
R. Schlingemann THE NETHERLANDS
The 12-month efficacy and safety of ranibizumab monotherapy or adjunctive with laser versus laser in diabetic
macular edema patients of restore |
11.16 |
F. Bandello, J. Haller, A. Loewenstein, J. Jiao, X. Li, S. Whitcup ITALY
12-Month Evaluation of Dexamethasone Intravitreal Implant in Patients with Macular Edema due to Central Retinal
Vein Occlusion |
11.24 |
N. Borah, S. Ahmed INDIA
Long term results of intra vitreal bevacizumab in macular edema secondary to central retinal vein occlusion |
11.32 |
I. Chowers, J. Vicuna-Kojchen, R. Garza ISRAEL
Association of Macular Ischemia and Additional Clinical and Demographic Factors with Visual Acuity in Eyes with
Diabetic Retinopathy |
11.40 |
E. Costa, L. Cristóvão, J.R. Faria de Abreu PORTUGAL
Diabetic Retinopathy Screening in Central Portugal (2001-2010) |
11.48 |
C. Favard FRANCE
Pascal Laser for the treatment of Macular Oedema |
11.56 |
J. Figueira, FAME Studies Group PORTUGAL
Fluocinolone Acetonide Intravitreal Insert (Iluvien®) Phase 3 studies: Reduced overall risk of procedures to treat diabetic retinopathy and elevated IOP |
12.04 |
K.C.S. Fong, L. Ong, I. Tajunisah, M. Nor Fadhilah MALAYSIA
Early results comparing micropulse yellow 577nm Laser with green 532nm Laser for diabetic macular oedema |
12.12 |
N. Franqueira, P. Fonseca, M.L. Cachulo, I. Pires, R. Silva PORTUGAL
Ranibizumab for choroidal neovascularization in pathologic myopia: 24-month outcomes |
12.20 |
A. Freton, P. Gastaud FRANCE
Indocyanine green angiography-assisted focal laser treatment for diabetic macular oedema |
12.28 |
J.G. Garweg SWITZERLAND
Visual acuity response to ranibizumab stratified by baseline characteristics in diabetic macular edema (dme)
in the resolve study |
12.36 |
D. Gaucher, I. Fournier, M. Saleh, T. Bourcier, M.H. Metz-Boutigue FRANCE
Vitreous Expression and Processing of Chromogranins in Patients With Diabetic Retinopathy |
12.44 |
C. Gonzalez FRANCE
Treatment of Type 1 idiopathic Macular Telangiectasia by series of 3 Ranibizumab injections after 1 year follow-up |
12.52 |
B. Gupta, J. Evans, S. Sivaprasad UK
Visual Impairment in Various Ethnic Groups in Diabetic population (DRIVE UK Study) |
13.00 |
End of session |
